{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:54:29Z","timestamp":1791172469828,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd015096","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000}}],"reference-count":72,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd015096.pub2","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:02:23Z","timestamp":1779289343000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Perioperative use of disease-modifying anti-rheumatic drugs (DMARDs) in people with inflammatory arthritis"],"prefix":"10.1002","volume":"2026","author":[{"given":"Ville","family":"Ponkilainen","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics and Traumatology; Tampere University Hospital and Tampere University; Tampere Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5650-895X","authenticated-orcid":false,"given":"Teemu V","family":"Karjalainen","sequence":"additional","affiliation":[{"name":"Center for Musculoskeletal Disease; Tampere University Hospital and Tampere University; Tampere Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilari","family":"Kuitunen","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine; University of Eastern Finland; Kuopio Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Uimonen","sequence":"additional","affiliation":[{"name":"Department of Cardiology; Heart Hospital, Tampere University Hospital; Tampere Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renea V","family":"Johnston","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine; Monash University; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Saarinen","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics and Traumatology; Turku University Hospital, University of Turku; Turku Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel L","family":"Whittle","sequence":"additional","affiliation":[{"name":"Rheumatology Unit; Queen Elizabeth Hospital; Woodville South Australia"},{"name":"School of Public Health and Preventive Medicine; Monash University; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Glennon","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine; Monash University; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesl","family":"Grobler","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine; Monash University; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Horrigan","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine; Monash University; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Cyril","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine; Monash University; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachelle","family":"Buchbinder","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine; Monash University; Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"issue":"10159","key":"10.1002\/14651858.CD015096.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators","year":"2018","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0002|cit2","first-page":"5","article-title":"Social and economic impact of inflammatory arthritis","volume":"Spec No","author":"Bergman","year":"2006","journal-title":"Postgraduate Medicine"},{"issue":"2","key":"10.1002\/14651858.CD015096.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0889-857X(05)70201-5","article-title":"The epidemiology of rheumatoid arthritis","volume":"27","author":"Gabriel","year":"2001","journal-title":"Rheumatic diseases clinics of North America"},{"issue":"1","key":"10.1002\/14651858.CD015096.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G","article-title":"Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors","volume":"41","author":"Braun","year":"1998","journal-title":"Arthritis and rheumatism"},{"issue":"2","key":"10.1002\/14651858.CD015096.pub2-BIB0005|cit5","first-page":"e001214","article-title":"Should we stop or continue conventional synthetic (including glucocorticoids) and targeted DMARDs before surgery in patients with inflammatory rheumatic diseases?","volume":"6","author":"Goodman","year":"2020","journal-title":"Rheumatic and Musculoskeletal Diseases Open"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"386","DOI":"10.6061\/clinics\/2017(06)09","article-title":"Perioperative management of drugs commonly used in patients with rheumatic diseases: a review","volume":"72","author":"Franco","year":"2017","journal-title":"Clinics"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1007\/s00296-006-0138-z","article-title":"Leflunomide increases the risk of early healing complications in patients with rheumatoid arthritis undergoing elective orthopedic surgery","volume":"26","author":"Fuerst","year":"2006","journal-title":"Rheumatology International"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/ard.60.3.214","article-title":"Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery","volume":"60","author":"Grennan","year":"2001","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0009|cit9","first-page":"1129","article-title":"Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis","volume":"20","author":"Sany","year":"1993","journal-title":"Journal of Rheumatology"},{"issue":"8","key":"10.1002\/14651858.CD015096.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/acr.23274","article-title":"2017 American College of Rheumatology\/American Association of Hip and Knee Surgeons: guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty","volume":"69","author":"Goodman","year":"2017","journal-title":"Arthritis Care & Research"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0011|cit11","unstructured":"An Australian living guideline for the pharmacological management of inflammatory arthritis mskguidelines.org 1.15"},{"issue":"2","key":"10.1002\/14651858.CD015096.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3899\/jrheum.121306","article-title":"Updated method guidelines for Cochrane musculoskeletal group systematic reviews and metaanalyses","volume":"41","author":"Ghogomu","year":"2014","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0013|cit13","unstructured":"Brooker J Synnot A McDonald S Elliott J Turner T Guidance for the production and publication of Cochrane living systematic reviews: Cochrane Reviews in living mode https:\/\/community.cochrane.org\/review-development\/resources\/living-systematic-reviews (accessed 19 December 2023) 1.0"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jclinepi.2017.08.010","article-title":"Living systematic reviews: 1. Introduction - the why, what, when and how","volume":"91","author":"Elliott","year":"2017","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"e028576","DOI":"10.1136\/bmjopen-2018-028576","article-title":"What is an invasive procedure? A definition to inform study design, evidence synthesis and research tracking","volume":"9","author":"Cousins","year":"2019","journal-title":"BMJ Open"},{"issue":"Suppl 39","key":"10.1002\/14651858.CD015096.pub2-BIB0016|cit16","first-page":"S100","article-title":"The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis","volume":"23","author":"Aletaha","year":"2005","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD015096.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/ard.2011.149765","article-title":"American College of Rheumatology\/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials","volume":"70","author":"Felson","year":"2011","journal-title":"Annals of Rheumatic Disease"},{"issue":"2","key":"10.1002\/14651858.CD015096.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/rheumatology\/keg072","article-title":"A simplified disease activity index for rheumatoid arthritis for use in clinical practice","volume":"42","author":"Smolen","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1002\/14651858.CD015096.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3899\/jrheum.150826","article-title":"Defining low disease activity states in psoriatic arthritis using novel composite disease instruments","volume":"43","author":"Coates","year":"2016","journal-title":"Journal of Rheumatology"},{"issue":"1","key":"10.1002\/14651858.CD015096.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/ard.2010.138594","article-title":"Assessment of Spondyloarthritis International Society. Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores","volume":"70","author":"Machado","year":"2011","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"1","key":"10.1002\/14651858.CD015096.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis and Rheumatism"},{"issue":"12","key":"10.1002\/14651858.CD015096.pub2-BIB0022|cit22","first-page":"2286\u201391","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garrett","year":"1994","journal-title":"Journal of Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD015096.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/art.1780230202","article-title":"Measurement of patient outcome in arthritis","volume":"23","author":"Fries","year":"1980","journal-title":"Arthritis & Rheumatology"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0024|cit24","unstructured":"Covidence Veritas Health Innovation 2023"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0026|cit26","unstructured":"Cochrane Register of Studies crsweb.cochrane.org\/login.html"},{"issue":"6","key":"10.1002\/14651858.CD015096.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/jamia\/ocx053","article-title":"Identifying reports of randomized controlled trials (RCTs) via a hybrid machine learning and crowd sourcing approach","volume":"24","author":"Wallace","year":"2017","journal-title":"Journal of the American Medical Informatics Association"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0028|cit28","unstructured":"Review Manager The Cochrane Collaboration 2024"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0029|cit29","unstructured":"WebPlotDigitizer Ankit Rohatgi 2021"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0030|cit30","unstructured":"Higgins JPT Altman DG Sterne JAC Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, Li T, Page MJ, et al (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017 Available from training.cochrane.org\/handbook\/archive\/v5.2\/"},{"issue":"4","key":"10.1002\/14651858.CD015096.pub2-BIB0031|cit31","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008205.pub3","article-title":"Hepatic late adverse effects after antineoplastic treatment for childhood cancer","author":"Mulder","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0032|cit32","unstructured":"Higgins JPT Li T Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"480","DOI":"10.7326\/M16-2458","article-title":"Systemic pharmacologic therapies for low back pain: a systematic review for an American College of Physicians clinical practice guideline","volume":"166","author":"Chou","year":"2017","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0034|cit34","unstructured":"Deeks JJ Higgins JPT Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0035|cit35","unstructured":"Page MJ Higgins JPT Sterne JAC Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0036|cit36","unstructured":"Higgins JPT Thomas J Chandler J Cumpston M Li T Page MJ Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane, 2024 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"l6890","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0038|cit38","unstructured":"Schmid C Chandler J Senn S Sterne J Kulinskaya E Posch M et al; Cochrane Scientific Committee\u00a0 Should Cochrane apply error-adjustment methods when conducting repeated meta-analyses? methods.cochrane.org\/sites\/default\/files\/public\/uploads\/tsa_expert_panel_guidance_and_recommendation_final.pdf"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0039|cit39","unstructured":"Sch\u00fcnemann HJ Higgins JPT Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023 Available from training.cochrane.org\/handbook"},{"issue":"3","key":"10.1002\/14651858.CD015096.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jphys.2023.05.012","article-title":"Research Note: Interpreting findings of a systematic review using GRADE methods","volume":"69","author":"Brennan","year":"2023","journal-title":"Journal of Physiotherapy"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jclinepi.2022.07.014","article-title":"GRADE Guidance 34: update on rating imprecision using a minimally contextualized approach","volume":"150","author":"Zeng","year":"2022","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0042|cit42","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime, Inc.) 2023"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0043|cit43","unstructured":"Sch\u00fcnemann HJ Vist GE Higgins JPT Santesso N Deeks JJ Glasziou P Chapter 15: Interpreting results and drawing conclusions. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023 Available from training.cochrane.org\/handbook"},{"issue":"2","key":"10.1002\/14651858.CD015096.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3899\/jrheum.2023-0530","article-title":"Initiating evaluation of composite outcome measures for psoriatic arthritis: 2022 updates from the GRAPPA-OMERACT Working Group","volume":"50","author":"Leung","year":"2023","journal-title":"Journal of Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD015096.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/ard.60.3.214","article-title":"Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery","volume":"60","author":"Grennan","year":"2001","journal-title":"Annals of Rheumatic Diseases"},{"issue":"7","key":"10.1002\/14651858.CD015096.pub2-BIB0046|cit46","first-page":"1129","article-title":"Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis","volume":"20","author":"Sany","year":"1993","journal-title":"Journal of Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD015096.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.RHU.0000062514.54375.bd","article-title":"Examination of the risk of continuous leflunomide treatment on the incidence of infectious complications after joint arthroplasty in patients with rheumatoid arthritis","volume":"9","author":"Tanaka","year":"2003","journal-title":"Journal of Clinical Rheumatology"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD015096.pub2-BIB0048|cit48","first-page":"466","article-title":"Does Stopping of Molecular Target Drugs Increase Postoperative Complications after Orthopaedic Surgeries in Patients with Rheumatoid Arthritis?","volume":"83","author":"Ito","year":"2024","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0049|cit49","first-page":"(suppl 10)","article-title":"Postoperative Complications Rate in Orthopaedic Surgery Performed in Rheumatic Patients in Use of Biologic Agents [abstract]","volume":"67","author":"Queiroz Pimentel","year":"2015","journal-title":"Arthritis Rheumatology"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/annrheumdis-2014-eular.1735","article-title":"FRI0022\u2005Influence of Biologic Agents on Postoperative Infection in Rheumatoid Arthritis Patients","volume":"73","author":"Tada","year":"2014","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD015096.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/annrheumdis-2023-eular.2663","article-title":"The Effect of Perioperative Janus Kinase Inhibitor Withdrawal on Surgical Site Infection and Flare of Rheumatoid Arthritis in Orthopedic Surgery: A Multi-Center Observational Study","volume":"82","author":"Yoshida","year":"2023","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"6","key":"10.1002\/14651858.CD015096.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"e084997","DOI":"10.1136\/bmjopen-2024-084997","article-title":"PERI-operative biologic DMARD management: Stoppage or COntinuation during orthoPaEdic operations (the PERISCOPE trial) - a study protocol for a pragmatic, UK multicentre, superiority randomised controlled trial with an internal pilot, economic evaluation and nested qualitative study","volume":"14","author":"Brady","year":"2023","journal-title":"BMJ Open. 2024"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0053|cit53","unstructured":"PERI-operative biologic DMARD management: Stoppage or COntinuation during orthoPaEdic operations: The PERISCOPE trial https:\/\/www.isrctn.com\/ISRCTN17691638"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0054|cit54","unstructured":"Anti-TNF\u03b1 Use During Elective Foot and Ankle Surgery in Patients With Rheumatoid Arthritis https:\/\/clinicaltrials.gov\/study\/NCT02242474"},{"issue":"12","key":"10.1002\/14651858.CD015096.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/acr.23209","article-title":"Perioperative timing of infliximab and the risk of serious infection after elective hip and knee arthroplasty","volume":"69","author":"George","year":"2017","journal-title":"Arthritis Care & Research"},{"issue":"5","key":"10.1002\/14651858.CD015096.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3109\/17453674.2013.842431","article-title":"Continuation of TNF blockade in patients with inflammatory rheumatic disease. An observational study on surgical site infections in 1,596 elective orthopedic and hand surgery procedures","volume":"84","author":"Berthold","year":"2013","journal-title":"Acta Orthopaedica"},{"issue":"4","key":"10.1002\/14651858.CD015096.pub2-BIB0057|cit57","first-page":"689","article-title":"Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study","volume":"34","author":"Den Broeder","year":"2007","journal-title":"Journal of Rheumatology"},{"issue":"9","key":"10.1002\/14651858.CD015096.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/acr.23843","article-title":"Timing of abatacept before elective arthroplasty and risk of postoperative outcomes","volume":"71","author":"George","year":"2019","journal-title":"Arthritis Care & Research"},{"issue":"1","key":"10.1002\/14651858.CD015096.pub2-BIB0059|cit59","first-page":"1","article-title":"Perioperative use of methotrexate and tumor necrosis factor \u03b1 inhibitors combination therapy is not likely to increase post-operative infection rate in the National Veterans Health Administration Administrative Databases","volume":"9","author":"Peck","year":"2019","journal-title":"Open Journal of Rheumatology and Autoimmune Diseases"},{"issue":"3","key":"10.1002\/14651858.CD015096.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3928\/0147-7447-19960301-09","article-title":"Postoperative joint infections in rheumatoid arthritis patients on methotrexate therapy","volume":"19","author":"Carpenter","year":"1996","journal-title":"Orthopedics"},{"issue":"1","key":"10.1002\/14651858.CD015096.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3109\/s10165-005-0444-4","article-title":"Lack of increase in postoperative complications with low-dose methotrexate therapy in patients with rheumatoid arthritis undergoing elective orthopedic surgery","volume":"16","author":"Murata","year":"2006","journal-title":"Modern Rheumatology"},{"issue":"13","key":"10.1002\/14651858.CD015096.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/BRS.0000000000003402","article-title":"Impact of chronic DMARD therapy in patients with rheumatoid arthritis undergoing surgery of the craniovertebral junction: a multi-center retrospective study","volume":"45","author":"Elia","year":"2020","journal-title":"Spine"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.knee.2022.12.017","article-title":"Postoperative flares and peri-arthroscopic management of immunosuppressive medications in patients with rheumatic disease","volume":"41","author":"Vasavada","year":"2023","journal-title":"Knee"},{"issue":"6","key":"10.1002\/14651858.CD015096.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/SLA.0000000000003581","article-title":"Perioperative probiotics or synbiotics in adults undergoing elective abdominal surgery: a systematic review and meta-analysis of randomized controlled trials","volume":"271","author":"Chowdhury","year":"2020","journal-title":"Annals of Surgery"},{"issue":"1","key":"10.1002\/14651858.CD015096.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/17453674.2020.1843875","article-title":"Total hip arthroplasties in the Dutch Arthroplasty Register (LROI) and the Nordic Arthroplasty Register Association (NARA): comparison of patient and procedure characteristics in 475,685 cases","volume":"92","author":"Van Steenbergen","year":"2021","journal-title":"Acta Orthopaedica"},{"issue":"4","key":"10.1002\/14651858.CD015096.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3109\/17453674.2015.1017793","article-title":"Increased risk of revision for infection in rheumatoid arthritis patients with total hip replacements: a study of 390,671 primary arthroplasties from the Nordic Arthroplasty Register Association","volume":"86","author":"Schrama","year":"2015","journal-title":"Acta Orthopaedica"},{"issue":"1","key":"10.1002\/14651858.CD015096.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00296-011-2040-6","article-title":"Should anti-TNF therapy be discontinued in rheumatoid arthritis patients undergoing elective orthopaedic surgery? A systematic review of the evidence","volume":"32","author":"Goh","year":"2012","journal-title":"Rheumatology International"},{"issue":"3","key":"10.1002\/14651858.CD015096.pub2-BIB0068|cit68","first-page":"573","article-title":"Management of perioperative tumour necrosis factor \u03b1 inhibitors in rheumatoid arthritis patients undergoing arthroplasty: a systematic review and meta-analysis","volume":"55","author":"Goodman","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1002\/14651858.CD015096.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.semarthrit.2006.10.003","article-title":"Patients with rheumatoid arthritis undergoing surgery: how should we deal with antirheumatic treatment?","volume":"36","author":"Pieringer","year":"2007","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"5","key":"10.1002\/14651858.CD015096.pub2-BIB0070|cit70","first-page":"856","article-title":"A systematic review on the optimum management of the use of methotrexate in rheumatoid arthritis patients in the perioperative period to minimize perioperative morbidity and maintain disease control","volume":"27","author":"Loza","year":"2009","journal-title":"Clinical & Experimental Rheumatology"},{"issue":"5","key":"10.1002\/14651858.CD015096.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3109\/14397595.2015.1014302","article-title":"Postoperative complications in patients with rheumatoid arthritis using a biological agent \u2013 A systematic review and meta-analysis","volume":"25","author":"Ito","journal-title":"Mod Rheumatol"},{"key":"10.1002\/14651858.CD015096.pub2-BIB0072|cit72","first-page":"1381","article-title":"TNF blockade during elective orthopaedic and hand surgery in arthritis patients: Friend or foe?","volume":"62 (SUPPL. 10)","author":"Pettersson","year":"2010","journal-title":"Arthritis & Rheumatism"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:46:10Z","timestamp":1791171970000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD015096.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":72,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd015096.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]}}}